Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. (Q47696284)

4 February 2018

review article

1 reference

title

Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. (English)

1 reference

4 February 2018

1 reference

1 reference

Jilka RL

1

1 reference

4 February 2018

publication date

1 August 1998

1 reference

4 February 2018

published in

Bone

1 reference

4 February 2018

volume

23

1 reference

4 February 2018

page(s)

75-81

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Role of colony-stimulating factor-1 in bone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Apoptosis in bone physiology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Inhibition of parathormone-stimulated bone resorption by type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Osteoclast demise in the rat: physiological versus degenerative cell death

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Isolation and characterization of the human gp130 promoter. Regulation by STATS.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Mechanisms and genes of cellular suicide

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Androgen treatment prevents loss of cancellous bone in the orchidectomized rat

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

A study of intercellular relationships between trabecular bone and marrow stromal cells in the murine femoral metaphysis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Correction: raloxifene response needs more than an element

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

Transforming growth factor beta 1 stimulates bone formation and resorption in an in-vivo model in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900077-5

7 January 2021

10.1016/S8756-3282(98)00077-5

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

9701464

1 reference

4 February 2018